where science
​meets EXCELLENCE.

Building F is a new state-of-the-art R&D facility situated at the heart of the thriving, ±800,000 SF, New Jersey Center of Excellence campus

Building F

Building F is a new state-of-the-art R&D facility situated at the heart of the thriving, ±800,000 SF, New Jersey Center of Excellence campus, set on 110 picturesque acres in Bridgewater, New Jersey. This premier and vibrant Hi-Tech/R&D campus is centrally located within the Boston to Washington, D.C. life science corridor, positioned south of Interstate 78/287 interchange in Somerset County, and is home to a growing list of prestigious tenants, including Avantor, Ashland, Kashiv Pharmaceuticals, NestléHealth- Science, Nevakar and PTC Therapeutics.

​As the newest building in the campus, this 66,000 SF three-story, column free, high-tech, lab facility will utilize cutting edge technologies including direct dispatch elevators and touchless features; and will offer a modern, collaborative and healthy work environment for R&D companies.
​For more information, please contact exclusive leasing broker, JLL:
​Dan Loughlin, SIOR
​+1 973 829 4695
​dan.loughlin@jll.com
​Craig Eisenhardt
​+1 973 829 4680
​craig.eisenhardt@jll.com
​Bob Ryan
​+1 973 829 4717
bobs.ryan@jll.com
An investment property of:
Site powered by Weebly. Managed by JLL - AM
Although information has been obtained from sources deemed reliable, neither Owner nor JLL makes any guarantees, warranties or representations, express or implied, as to the completeness or accuracy as to the information contained herein. Any projections, opinions, assumptions or estimates used are for example only. There may be differences between projected and actual results, and those differences may be material. The Property may be withdrawn without notice. Neither Owner nor JLL accepts any liability for any loss or damage suffered by any party resulting from reliance on this information. If the recipient of this information has signed a confidentiality agreement regarding this matter, this information is subject to the terms of that agreement. ©2022. Jones Lang LaSalle IP, Inc. All rights reserved.
Privacy Statement | Privacy Commitment | Cookie Policy